Melleva

Ethinylestradiol and Levonorgestrel, the active ingredients in Melleva, are a combined oral contraceptive presented as an oral tablet for oral use. They work to prevent pregnancy in women of reproductive age by inhibiting ovulation, altering cervical mucus, and inducing endometrial changes.

GNH USA supplies Melleva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global logistics for regulated medicines, ensuring timely delivery and compliance with local regulatory requirements.

Melleva, a combined oral contraceptive, is indicated for hormonal contraception to prevent pregnancy and related menstrual conditions. - Contraception: prevents pregnancy in women of reproductive age. - Menstrual cycle regulation: helps establish regular menstrual cycles and reduces heavy bleeding. - Acne treatment: decreases acne lesions by reducing androgenic activity in the skin.

Melleva may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort in the breasts. - Spotting between periods: light vaginal bleeding.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot traveling to lungs, potentially life‑threatening. - Hepatic adenoma: benign liver tumor.

Before prescribing Melleva, clinicians should consider several safety measures. - Assess thromboembolic risk: evaluate personal and family history of clotting disorders. - Screen for hypertension: measure blood pressure before initiating therapy. - Advise smoking cessation: avoid use in women over 35 who smoke. - Monitor liver function: use with caution in hepatic impairment. - Review concomitant medications: check for drugs that may reduce effectiveness. - Store at ambient temperature: keep tablets in original packaging, protect from moisture and light.

Melleva can interact with other medicines, requiring attention to the level of risk.

Major Interactions (Avoid): - Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin): may markedly reduce contraceptive efficacy. - Antiretroviral protease inhibitors (e.g., ritonavir): can increase hormone levels and risk of side effects. - St. John’s wort: herbal inducer that may decrease plasma concentrations of the hormones.

Moderate Interactions (Monitor Closely): - Certain antibiotics (e.g., tetracycline, metronidazole): may slightly lower effectiveness. - Antifungal agents (e.g., fluconazole): can increase hormone exposure. - Diuretics (e.g., spironolactone): may exacerbate fluid retention and blood pressure changes.